NeuroPace (NPCE) EBT (2020 - 2026)

NeuroPace has reported EBT for 7 years, with the latest figure at -$6.2 million in Q2 2026.

• On a quarterly basis, EBT rose 35.37% year-over-year to -$6.2 million in Q2 2026; TTM through Jun 2026 was -$19.0 million, a 29.33% increase from a year earlier, with the FY2025 full-year figure at -$21.0 million, up 23.56% from the prior year.
• EBT was -$6.2 million for Q2 2026 at NeuroPace, up from -$6.5 million in the prior quarter.
• The five-year high for EBT was -$2.7 million in Q4 2025, with the low at -$12.6 million in Q2 2022.
• Average EBT over 5 years is -$7.9 million, with a median of -$7.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: EBT slumped 101.12% in 2022, then surged 47.15% in 2025.
• Over 5 years, EBT stood at -$11.0 million in 2022, then jumped by 41.23% to -$6.5 million in 2023, then grew by 20.12% to -$5.2 million in 2024, then soared by 47.15% to -$2.7 million in 2025, then plunged by 125.69% to -$6.2 million in 2026.
• The last three EBT figures came in at -$6.2 million (Q2 2026), -$6.5 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.